Trader TV Watchlist - January 21, 2026

Wednesday January 21, 2026

Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.

TraderTV.LIVE™ features a daily live trading broadcast, professional education and an active community of more than 450,000 subscribers. Join us on YouTube every weekday from 8:30am to 4:30pm EST for the first and only professional trading show on YouTube Live!

Economic Events:

0830 - Core PCE m/m: Expected -0.3%; Prior - 0.2%
0830 - Core PCE y/y: Expected 2.9%; Prior 2.8%
0830 - PCE Price m/m: Expected 0.3%; Prior 0.2%
0830 - PCE Price y/y: Expected 2.8%; Prior 2.8%
0830 - GDP: Expected -2.8%; Prior 4.4%
0945 - S&P Global Manucturing PMI: Expected -52.4; Prior 52.4%
0945 - Fed’s Bostic Speaks

1000 - Michigan Consumer Sentiment: Expected 57.3; Prior 56.4

Premarket Trading:

Trading Higher ($): GOOGL, OPEN, CELH

Trading Lower ($): BABA, OWL, NEM

Earnings Today:

Premarket: AU, WU, DNOW

In The News

Nvidia Inc (NVDA)

-0.51%

Nvidia has replaced its speculative $100 billion infrastructure plan with a firm $30 billion equity stake in OpenAI, valued at a massive $730 billion pre-money valuation. This move decouples the investment from specific computing power milestones, providing both companies with greater strategic flexibility. CEO Sam Altman dismissed rumors of a partnership rift as "insanity," confirming that OpenAI remains a committed long-term customer and plans to integrate Nvidia’s next-generation Vera Rubin architecture into its hardware portfolio.

Opendoor Technologies (OPEN)

17.42%

Opendoor shares are trading higher after a double beat in Q4, with revenue of $736 million and an adjusted loss of $0.07 per share both coming in better than analyst forecasts. Key wins included a 46% surge in home acquisitions and a significant improvement in inventory health, with the share of "stale" listings (120+ days) dropping to 33%. While management issued a cautious 10% year-over-year revenue decline for Q1 2026, they expect a major rebound in profitability, projecting the highest contribution margins in nearly two years by the end of next quarter.

Tesla Inc. (TSLA)

-0.25%

Trading slightly lower premarket, Tesla has introduced a new entry-level Dual Motor AWD Cybertruck priced at $59,990, while simultaneously cutting the top-tier Cyberbeast price to $99,990 by removing the "Luxe" feature package. Despite these price drops, Future Fund's Gary Black remains skeptical, predicting that 2026 sales will stall at 25,000 units—only a slight increase from 2025.

Blue Owl Capital Inc (OWL)

-1.45%

Trading lower again today, Blue Owl Capital is liquidating $1.4 billion in assets across three credit funds to facilitate investor payouts and reduce debt. In a significant move, the firm has also permanently suspended redemptions for one of these funds. These actions come as the broader private equity sector, specifically direct lending and software-focused stocks, faces a sharp market selloff.

Akamai Technologies Inc (AKAM)

-11.03%

Trading sharply lower in the premarket, Akamai has issued a first-quarter profit forecast of $1.50 to $1.67 per share, falling short of the $1.75 analyst consensus due to a global memory supply squeeze. CEO Tom Leighton revealed that memory costs have roughly doubled in recent months, forcing the company to consider careful price hikes for customers to offset these rising expenses. This strategic shift highlights the broader pressure on tech infrastructure firms as they struggle to maintain margins amidst skyrocketing component prices.

Meta Platforms Inc. (META)

-0.34%

According to a Financial Times report, Meta has reduced its annual stock option grants by approximately 5% for the majority of its staff, marking the second consecutive year of scaled-back equity awards. This shift allows CEO Mark Zuckerberg to redirect billions toward the company's ambitious AI goals, with 2026 capital expenditures projected to reach between $115 billion and $135 billion. By tightening employee compensation, the social media giant is prioritizing the massive infrastructure spending required for its long-term technological objectives.

Grail Inc (GRAL)

-47.24%

Shares plummeted nearly 47% in premarket trading. This following disappointing results from the landmark NHS-Galleri trial. While the blood-based screening test showed a "favorable trend," it failed to meet its primary clinical endpoint of a statistically significant reduction in combined Stage III and IV cancer diagnoses across the 142,000-participant study.